Belite Bio, Inc (BLTE) Stock Overview
Explore Belite Bio, Inc’s financial performance, market position, analyst ratings, and future outlook.
Belite Bio, Inc (BLTE)
Key Financials
Key Financials
Market Cap
6.7B
P/E Ratio
-60.50
EPS (TTM)
$-1.87
ROE
-0.16%
BLTE Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Belite Bio, Inc (NASDAQ: BLTE) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Belite Bio, Inc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BLTE on the NASDAQ shows an RSI of 47.12, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $201.57 for the NASDAQ listing.
Key metrics behind Belite Bio, Inc's NASDAQ-traded stock include a P/E ratio of -60.50 and a market capitalization of 6.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BLTE on the NASDAQ.